Anixa Biosciences, Inc. (ANIX)
3.13
+0.02
(+0.64%)
USD |
NASDAQ |
Jan 21, 10:55
Anixa Biosciences Total Assets (Quarterly): 16.08M for Oct. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.55B |
| Boston Scientific Corp. | 42.71B |
| Puma Biotechnology, Inc. | 202.86M |
| CEL-SCI Corp. | 28.16M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.13M |
| Shareholders Equity (Quarterly) | 15.16M |
| Debt to Equity Ratio | 0.0135 |
| Current Ratio | 8.077 |
| Net Debt Paydown Yield | 0.00% |